Tradestie Institutional Equity Comparison Engine

UFPT vs HAE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HAE Overall Edge

HAE Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Haemonetics Corporation (HAE) driven by superior Valuation, Momentum & Technical, Options & Structure while UFPT counters with relative strength in Growth & Margin. Fundamentally, UFPT trades at 24.7x Forward P/E with 15.4% operating margin (+11.6% YoY revenue) versus HAE at 22.9x Forward P/E and 18.8% operating margin (+9.3% YoY). In options structure, UFPT sits in UNCLASSIFIED (3rd %ile IV; Dealer Gamma Walls on Pro) against HAE sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner HAE
UFPT 24.7x vs HAE 22.9x Fwd P/E
Growth & Margin Winner UFPT
Op Margin 15.4% vs 18.8% ยท YoY +11.6% vs +9.3%
Momentum & Technical Winner HAE
1Y +27.4% vs +64.2% ยท 52W Pos 74% vs 87%
Options & Structure Winner HAE
UNCLASSIFIED (3rd %ile IV) vs UNCLASSIFIED (2nd %ile IV)
UFPT NASDAQ
UFP Technologies Inc
Surgical & Medical Instruments & Apparatus
$298.54
-2.14% 1D
Market Cap $2.4B
1M Return +2.36%
1Y Return +27.42%
Forward P/E 24.7x
Unified AI Score
42.6 / 100 HOLD
Tech 25.0 Fund 37.0 Flow 50.0 Mom 40.0
HAE NYSE
Haemonetics Corporation
Surgical & Medical Instruments & Apparatus
$121.34
-1.3% 1D
Market Cap $5.6B
1M Return +2.59%
1Y Return +64.17%
Forward P/E 22.9x
Unified AI Score
51.4 / 100 HOLD
Tech 53.0 Fund 47.0 Flow 50.0 Mom 36.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: UFPT +27.42% HAE +64.17% Spread: +36.75 pp (HAE Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
UFPT TTM Op. Margin: 15.4% HAE TTM Op. Margin: 18.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UFPT vs HAE. Trailing 12-month operating profitability (UFPT 15.4% vs HAE 18.8%) and valuation multiples (UFPT 24.7x vs HAE 22.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: UFPT (4) vs HAE (6)
Institutional Metric UFPT HAE Criterion Row Winner
Market Capitalization Scale $2.4B $5.6B Larger Scale HAE
Trailing P/E Ratio Valuation 31.2x 54.4x Lower Multiple UFPT
Forward P/E Ratio Valuation 24.7x 22.9x Lower Multiple HAE
Revenue Growth (YoY) Growth +11.6% +9.3% Higher Growth UFPT
Operating Margin (TTM) Profitability 15.4% 18.8% Higher Margin HAE
Net Profit Margin Profitability 11.8% 7.5% Higher Margin UFPT
Return on Equity (ROE) Capital Efficiency 17.2% 11.9% Higher ROE UFPT
52-Week Range Position Momentum 74% ($174โ€“$342) 87% ($51โ€“$132) Stronger Trend HAE
Beta / 30D Volatility Risk Regime 1.64ฮฒ ยท 77% Vol 0.27ฮฒ ยท 32% Vol Lower Realized Risk HAE
Unified Institutional Score Composite Signal 42.6 / 100 (HOLD) 51.4 / 100 (HOLD) Higher Composite HAE

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full UFPT vs HAE Buy Guide
UFPT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live UFPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
HAE UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live HAE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither UFPT nor HAE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.